CO2017001088A2 - Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas - Google Patents

Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas

Info

Publication number
CO2017001088A2
CO2017001088A2 CONC2017/0001088A CO2017001088A CO2017001088A2 CO 2017001088 A2 CO2017001088 A2 CO 2017001088A2 CO 2017001088 A CO2017001088 A CO 2017001088A CO 2017001088 A2 CO2017001088 A2 CO 2017001088A2
Authority
CO
Colombia
Prior art keywords
acid
mixture
fatty acids
palmitoylethanolamide
inflammatory
Prior art date
Application number
CONC2017/0001088A
Other languages
English (en)
Inventor
Raffaele Migliaccio
Antonella Sardei
Carmela Migliaccio
Original Assignee
Raffaele Migliaccio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffaele Migliaccio filed Critical Raffaele Migliaccio
Publication of CO2017001088A2 publication Critical patent/CO2017001088A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una mezcla que contiene hasta dos ácidos grasos seleccionados de entre el ácido palmítico, el ácido oleico, el ácido esteárico, el ácido linoleico, el ácido alfa-linolénico, el ácido gamma-linolénico, el ácido eicosapentaenoico, el ácido docosahexaenoico, el ácido azelaico y el ácido mirístico y la palmitoiletanolamida. En una forma de realización de la presente invención, dicha mezcla se caracteriza porque al menos uno de dichos hasta dos ácidos grasos está saturado. La presente invención también hace referencia al uso de la mezcla antes mencionada en el tratamiento de patologías inflamatorias y alérgicas.
CONC2017/0001088A 2014-08-08 2017-02-06 Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas CO2017001088A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20141474 2014-08-08
PCT/IB2015/055885 WO2016020828A1 (en) 2014-08-08 2015-08-03 Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies

Publications (1)

Publication Number Publication Date
CO2017001088A2 true CO2017001088A2 (es) 2017-04-28

Family

ID=51663273

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0001088A CO2017001088A2 (es) 2014-08-08 2017-02-06 Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas

Country Status (12)

Country Link
US (2) US9962355B2 (es)
EP (1) EP3177281B1 (es)
JP (3) JP7118642B2 (es)
CN (1) CN106714792A (es)
CA (1) CA2957700C (es)
CO (1) CO2017001088A2 (es)
DK (1) DK3177281T3 (es)
FI (1) FI3177281T3 (es)
IL (1) IL250271B2 (es)
MA (1) MA40417A (es)
TW (1) TWI727926B (es)
WO (1) WO2016020828A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3000868A1 (en) * 2015-10-07 2017-04-13 Cormedix Inc. Skin-penetrating formulation of taurolidine
CN109893520A (zh) * 2019-03-21 2019-06-18 中国科学院水生生物研究所 螺旋藻γ-亚麻酸的新用途
AU2020260090C9 (en) * 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use
IT202100024464A1 (it) * 2021-09-23 2023-03-23 Epitech Group S P A N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive
CN114209683A (zh) * 2021-12-22 2022-03-22 中南大学湘雅三医院 壬二酸在制备治疗炎症性肠病药物中的应用
WO2023177427A1 (en) * 2022-03-14 2023-09-21 Fera Diagnostics And Biologicals Corp. Fatty acid compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
IT1257697B (it) * 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
US5679667A (en) * 1992-04-24 1997-10-21 Lifegroup S.P.A. Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
WO1994000127A1 (en) 1992-06-19 1994-01-06 The Regents Of The University Of California Lipids for epidermal moisturization and repair of barrier function
EP0620000A3 (de) * 1992-12-18 1994-11-02 Rhone-Poulenc Rorer Gmbh Kosmetische und/oder pharmazeutische Verwendung von N-Acylalkanolaminen
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
JP2000159668A (ja) * 1998-11-26 2000-06-13 Nof Corp サイトカイン抑制剤
JP2000191525A (ja) * 1998-12-25 2000-07-11 Nof Corp 皮膚外用剤組成物
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US20020143059A1 (en) 2000-12-28 2002-10-03 Sreekumar Pillai Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package
DE10217131A1 (de) * 2001-07-31 2003-02-13 Kuhs Kosmetik Gmbh & Co Kg Topisch applizierbare Zusammensetzung sowie Werkstoffgemisch
US7447631B2 (en) 2002-06-17 2008-11-04 Dolby Laboratories Licensing Corporation Audio coding system using spectral hole filling
ATE464890T1 (de) * 2006-03-28 2010-05-15 Epitech Group Srl Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP5586482B2 (ja) 2008-02-22 2014-09-10 ライジェル ファーマシューティカルズ， インコーポレイテッド アテローム性動脈硬化症の治療のための２，４−ピリミジンジアミンの使用
DE202008007621U1 (de) 2008-06-04 2008-11-06 Zimmer, Bruno Kosmetisches und Nahrungsmittel aus unterschiedlichen Fettsäuren
JP2013521302A (ja) * 2010-03-02 2013-06-10 イマジネティクス，インコーポレイテッド ミリスチン酸を含む組成物およびその使用
CA2792278C (en) 2010-04-13 2019-05-14 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
ITMI20111284A1 (it) 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
CN103242262A (zh) * 2013-05-24 2013-08-14 厦门大学 N-脂肪酰基乙醇胺水解酶抑制剂及其合成方法和用途

Also Published As

Publication number Publication date
JP2017523230A (ja) 2017-08-17
FI3177281T3 (fi) 2024-03-13
CN106714792A (zh) 2017-05-24
WO2016020828A1 (en) 2016-02-11
EP3177281A1 (en) 2017-06-14
IL250271B (en) 2022-10-01
JP2023041806A (ja) 2023-03-24
JP7335475B2 (ja) 2023-08-30
IL250271B2 (en) 2023-02-01
US20170224645A1 (en) 2017-08-10
BR112017002474A2 (pt) 2017-12-05
US20180243254A1 (en) 2018-08-30
DK3177281T3 (da) 2024-03-11
CA2957700A1 (en) 2016-02-11
TWI727926B (zh) 2021-05-21
JP2021004260A (ja) 2021-01-14
JP7118642B2 (ja) 2022-08-16
EP3177281B1 (en) 2023-12-06
IL250271A0 (en) 2017-03-30
MA40417A (fr) 2017-06-14
US10149827B2 (en) 2018-12-11
US9962355B2 (en) 2018-05-08
CA2957700C (en) 2022-12-13
TW201609084A (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
CO2017001088A2 (es) Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas
CL2019003105A1 (es) Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560)
CY1122248T1 (el) Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων
ZA201704820B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
AR101192A1 (es) Composición nutricional que contiene mezclas de aceites y método de promoción de la digestión de grasas y lípidos
MX342216B (es) Composiciones de acidos grasos.
ZA201704821B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
GEP201606568B (en) Compositions for the treatment of neurologic disorders
CY1123942T1 (el) Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
GB201611497D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
GB201611503D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
PL2952209T3 (pl) Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego
GB201611499D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
GB201611500D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
ES2927760T8 (es) Esteres halogenados de ácidos grasos insaturados ciclopropanados para su utilización en el tratamiento de las enfermedades neurodegenerativas
AR095832A1 (es) Composición farmacéutica oral útil para el trastorno del déficit de atención e hiperactividad, suplemento nutricional y alimento que la comprenden y proceso para preparar la composición
GB201607617D0 (en) Use of EPA and DHA Omega3 Dietary supplementation and Omega6 polyunsaturated fatty acid dietary restriction to cure 2 type diabetes
MY178497A (en) Super hard palm oil based fraction
RU2011122400A (ru) Амиды полиненасыщенных жирных кислот, снижающие агрегацию тромбоцитов